For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| All Participants (Overall Study) | For all arms: DC vaccine Co-cultured With Melanoma Cells; DC Vaccine Pulsed With Tumor Cell Lysates; DC Vaccines Fused With Tumor Cells | None | None | 1 | 15 | 11 | 15 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hepatic-Other | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hemoglobin | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Fatigue (lethargy, malaise, asthenia) | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Constitutional Symptoms-Other | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fever (in the absence of neutropenia, where neutropenia is defined as AGC<1.0 x 10e9/L) | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dermatology/Skin-Other | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Diarrhea patients without colostomy | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Taste disturbance (dysgeusia) | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastrointestinal-Other | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dysphagia, esophagitis, odynophagia (painful swallowing) | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| SGPT (ALT) (serum glutamic pyruvic transaminase) | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Hepatic-Other | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Alkaline phosphatase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Infection (documented clinically or microbiologically) with grade 3 or 4 neutropenia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Musculoskeletal-Other | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Neurology-Other | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Dizziness/lightheadedness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Mood alteration-anxiety, agitation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Mood alteration-depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Tumor pain (onset or exacerbation of tumor pain due to treatment) | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Dyspnea (shortness of breath) | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Platelets | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Edema | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Flushing | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Injection site reaction | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Alopecia | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Dyspepsia/heartburn | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Lymphatics-Other | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Vertigo | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Neuropathic pain | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Neuropathy-sensory | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Pain-Other | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |